Norwegian biotech and krill-harvesting company Aker BioMarine achieved revenues of USD 67.9 million (EUR 68.4 million) and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of USD 18.8 million (EUR 18.9 million) in the Q3 2022, up year-over-year from USD 62 million (EUR 62.4 million) and USD 14.4 million (EUR 14.1 million), respectively.
According to the company’s Q3 2022 report, sales in its Ingredients segment climbed…
Photo courtesy of Aker BioMarine
